BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9286308)

  • 1. Additional chromosome abnormalities in transient abnormal myelopoiesis in Down's syndrome patients.
    Kounami S; Aoyagi N; Tsuno H; Suzuki H; Kitano N; Koike M
    Acta Haematol; 1997; 98(2):109-12. PubMed ID: 9286308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient abnormal myelopoiesis in Down's syndrome.
    Kurahashi H; Hara J; Yumura-Yagi K; Tawa A; Kawa-Ha K
    Leuk Lymphoma; 1992 Dec; 8(6):465-75. PubMed ID: 1297480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down's syndrome and leukemia: mechanism of additional chromosomal abnormalities.
    Goh K; Lee H; Miller G
    Am J Ment Defic; 1978 May; 82(6):542-8. PubMed ID: 148844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient abnormal myelopoiesis of infancy associated with trisomy 21.
    Homans AC; Verissimo AM; Vlacha V
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):392-9. PubMed ID: 8214361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down's Syndrome-Transient Abnormal Myelopoiesis and Acute Leukaemia.
    Bain B
    Leuk Lymphoma; 1991; 3(5-6):309-17. PubMed ID: 27467421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infants with Down's syndrome. Use of cytogenetic studies and in vitro colony assay for granulocyte progenitor to distinguish acute nonlymphocytic leukemia from a transient myeloproliferative disorder.
    de Alarcon PA; Patil S; Golberg J; Allen JB; Shaw S
    Cancer; 1987 Sep; 60(5):987-93. PubMed ID: 2955884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient myeloproliferative disorder in chromosomally normal newborn infant.
    Kalousek DK; Chan KW
    Med Pediatr Oncol; 1987; 15(1):38-41. PubMed ID: 2951583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "TAM"ing of the shrew-challenges in the diagnosis of Neonatal leukemia with Down's syndrome -A case report with literature review.
    Manohar S; Jayakumar N
    Indian J Pathol Microbiol; 2022; 65(3):699-701. PubMed ID: 35900507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transient abnormal myelopoiesis followed by acute leukemia in children with Down syndrome].
    Hatae Y; Takeda T; Nakadate H; Hatayama Y; Kishino T; Ogawa Y
    Rinsho Ketsueki; 1990 Dec; 31(12):1939-44. PubMed ID: 2150419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megakaryoblastic leukemia and Down's syndrome: a review.
    Zipursky A; Peeters M; Poon A
    Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
    D'Angelo G; Merlo P
    Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis.
    Fong CT; Brodeur GM
    Cancer Genet Cytogenet; 1987 Sep; 28(1):55-76. PubMed ID: 2955886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome.
    Kurahashi H; Hara J; Yumura-Yagi K; Murayama N; Inoue M; Ishihara S; Tawa A; Okada S; Kawa-Ha K
    Blood; 1991 Mar; 77(6):1161-3. PubMed ID: 1672097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptic deletions and inversions of chromosome 21 in a phenotypically normal infant with transient abnormal myelopoiesis: a molecular cytogenetic study.
    Kempski HM; Craze JL; Chessells JM; Reeves BR
    Br J Haematol; 1998 Nov; 103(2):473-9. PubMed ID: 9827922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome.
    Hayashi Y; Eguchi M; Sugita K; Nakazawa S; Sato T; Kojima S; Bessho F; Konishi S; Inaba T; Hanada R
    Blood; 1988 Jul; 72(1):15-23. PubMed ID: 2968822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient myeloproliferative disorder in a Down's neonate with rearranged T-cell receptor beta gene and evidence of in vivo maturation demonstrated by dual-colour flow cytometric DNA ploidy analysis.
    Kwong YL; Cheng G; Tang TS; Robertson EP; Lee CP; Chan LC
    Leukemia; 1993 Oct; 7(10):1667-71. PubMed ID: 8412331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic syndrome after regression of transient abnormal myelopoiesis in a Down syndrome infant: different clonal origin?
    Kounami S; Aoyagi N; Tsuno H; Suzuki H; Kobayashi M; Koike M
    Cancer Genet Cytogenet; 1998 Jul; 104(2):115-8. PubMed ID: 9666804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the blast cell population in two neonates with Down's syndrome and transient myeloproliferative disorder.
    Coulombel L; Derycke M; Villeval JL; Leonard C; Breton-Gorius J; Vial M; Bourgeois P; Tchernia G
    Br J Haematol; 1987 May; 66(1):69-76. PubMed ID: 2954579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonate with Down's syndrome and transient congenital leukemia. In vitro studies.
    Rogers PC; Kalousek DK; Denegri JF; Thomas JW; Baker MA
    Am J Pediatr Hematol Oncol; 1983; 5(1):59-64. PubMed ID: 6222664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute megakaryoblastic leukemia in Down's syndrome: report of a case and review of cytogenetic findings.
    Suarez CR; Le Beau MM; Silberman S; Fresco R; Rowley JD
    Med Pediatr Oncol; 1985; 13(4):225-31. PubMed ID: 3159953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.